- Opportunity and Forecast 2016 - 2025
Health issues are on rise along with rapid growth in obese population leading to changes in lifestyle preferences. Industry players offer various products such as meal replacements, food & beverages, green tea, low-calorie sweetener, and others used for weight loss and diet management. Per capita consumption of fast food has increased in developing countries along with diseases caused due to obesity. The market is witnessing an upsurge owing to increase in health disorders and changes in lifestyle.
Rise in number of obese & geriatric population, lifestyle changes, increase in disposable income, and low-calorie beverages are the factors that drive the growth of the global weight loss and diet management market. However, lack of substantial scientific evidence, unethical marketing strategies, and high cost of customization restrain the market growth. Ongoing innovations & technological advancements create lucrative opportunities for the market.
The global weight loss and diet management market is segmented on the basis of products, distribution channels, and geography. The products analyzed in the research are meal replacements, better-for-you-food & beverages, low-calorie sweeteners, weight loss supplements, and green tea. Based on distribution channel, the market is categorized into large retail, small retail, health & beauty stores, multilevel marketing, and online distribution. The market scenario is analyzed for different geographical regions, including North America, Asia-Pacific, Europe, and LAMEA.
Key manufacturers operating in the market include Abbott Nutrition/EAS, Acatris Inc, AHD International, AIDP Inc, Ajinomoto Co. Inc., Alpro Ltd., Amer Sports Corporation, Amylin Pharmaceuticals, and others. They have adopted different strategies such as mergers & acquisitions, collaborations, joint ventures, partnerships, and others to strengthen their position in the industry.
The United States Amniotic Membrane Market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Read More >>